Join
Live feed
·
PRReleasevia Quantisnow
Merrimack Pharmaceuticals Inc. logo

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

ByQuantisnow·Wall Street's wire, on your screen.
MACK· Merrimack Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MACK (Merrimack Pharmaceuticals Inc.) and more on Quantisnow.